# fac-03 — 2023 Nobel Prize Physiology or Medicine
**Block:** factual  |  **difficulty:** easy

**Prompt:**
Who received the 2023 Nobel Prize in Physiology or Medicine, and for what specific discovery?

**Expected answer (эталон):**
Katalin Karikó and Drew Weissman. For discoveries of nucleoside base modifications that enabled effective mRNA vaccines against COVID-19.

---
## FUSION-конфиги (judge-анализ; responses вынесены в resp_*.md)

### C1_west_closed
_западный закрытый фронтир_  
panel=[gpt-5.2, gemini-3.1-pro-preview, grok-4.3] | judge=gpt-5.2 | cost=$0.0837 | 100.7s | ptok=9351 ctok=1342 | retries=0

**consensus:**
  - Katalin Karikó and Drew Weissman received the 2023 Nobel Prize in Physiology or Medicine (verified via NobelPrize.org).
  - The prize citation was “for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19” (verified via NobelPrize.org).
  - Their work showed that incorporating nucleoside/base modifications into in‑vitro–transcribed mRNA avoids strong innate inflammatory responses, a key enabling step for effective mRNA vaccination (mechanistic framing verified via NobelPrize.org press materials).

**contradictions:**
  _(пусто)_

**unique_insights:**
  - {"model": "google/gemini-3.1-pro-preview", "insight": "Highlights that LNP delivery technology was also crucial for real-world mRNA vaccines, even though the Nobel award specifically credited nucleoside base modifications."}

**blind_spots:**
  - No response quotes the official Nobel citation verbatim and attributes it directly to NobelPrize.org (source grounding is missing).
  - None clearly distinguishes “nucleoside base modifications” (the awarded discovery) from broader “mRNA vaccine invention/development,” which involved many additional advances and contributors.
  - No response mentions the additional Nobel-described effect of base modifications: increased protein production/translation from mRNA (not just reduced inflammation).
  - No response names the key innate-sensing pathway emphasized in Nobel materials (e.g., Toll-like receptor recognition of unmodified in-vitro–transcribed RNA) or situates the discovery in that mechanism.
  - The “pseudouridine swap” is presented as definitive by one model; none notes that multiple modified nucleosides exist and that deployed COVID-19 vaccines use specific variants (e.g., N1-methylpseudouridine) beyond the simplified example.

**partial_coverage:**
  - {"models": ["google/gemini-3.1-pro-preview"], "point": "Adds a specific example of the modification (uridine → pseudouridine) as the pivotal change reducing inflammatory sensing."}
  - {"models": ["google/gemini-3.1-pro-preview"], "point": "Notes the foundational work was published in 2005 (i.e., well before the COVID-19 pandemic)."}
  - {"models": ["google/gemini-3.1-pro-preview"], "point": "Mentions lipid nanoparticle (LNP) delivery as another critical technology for mRNA vaccines (though not part of the Nobel citation)."}
  - {"models": ["openai/gpt-5.2", "google/gemini-3.1-pro-preview"], "point": "Explicitly explains the discovery in immunological terms (modified mRNA reduces unwanted inflammatory/innate immune responses), beyond repeating the official citation."}

### C2_cn_open
_открытый китайский фронтир (умн+умн)_  
panel=[deepseek-v4-pro, glm-5.1, kimi-k2.6] | judge=qwen3-235b-a22b-2507 | cost=$0.0384 | 101.8s | ptok=11043 ctok=1767 | retries=0

**consensus:**
  - Katalin Karikó and Drew Weissman received the 2023 Nobel Prize in Physiology or Medicine.
  - They were awarded for their discoveries concerning nucleoside base modifications in mRNA.
  - Their work enabled the development of effective mRNA vaccines against COVID-19.
  - They discovered that chemically modifying nucleoside bases in in vitro transcribed mRNA reduces inflammatory responses in dendritic cells.
  - Their 2005 study demonstrated that base modifications nearly abolish the immune system's recognition of synthetic mRNA as foreign.
  - Follow-up studies in 2008 and 2010 showed that base-modified mRNA increases protein production.
  - The increased protein production is due to reduced activation of an enzyme that regulates translation, specifically PKR.
  - The modifications involve altering bases (A, U, G, C) to mimic naturally occurring modifications in mammalian RNA, particularly the use of pseudouridine.

**contradictions:**
  _(пусто)_

**unique_insights:**
  - {"model": "deepseek/deepseek-v4-pro", "insight": "The dual benefit of nucleoside base modifications—reducing inflammatory responses and increasing protein production—eliminated critical barriers to clinical mRNA applications, which is a mechanistic synthesis not explicitly framed as such in the other responses."}

**blind_spots:**
  - None of the models mention specific types of chemical modifications used, such as pseudouridine, despite the Nobel press release and key 2008/2010 papers highlighting it.
  - The role of Toll-like receptors (TLRs) in recognizing unmodified mRNA and how base modifications suppress this pathway is absent in all responses, despite being in the primary source (Immunity 2005 paper).
  - No model references the prior challenges with mRNA instability and delivery requiring lipid nanoparticles, contextualizing why reduced immunogenicity alone was insufficient without delivery systems.
  - The broader implications beyond vaccines—such as therapeutic protein replacement or cancer immunotherapy—are only weakly implied and not explicitly discussed.

**partial_coverage:**
  - {"models": ["deepseek/deepseek-v4-pro"], "point": "The 2005 discovery showed that base modifications reduce activation of a protein that regulates translation, with later work identifying PKR as a key mediator."}
  - {"models": ["z-ai/glm-5.1", "moonshotai/kimi-k2.6"], "point": "The absence of chemical base modifications in lab-produced mRNA explains why it triggers inflammation, unlike mammalian mRNA."}

### C5_smartpanel_dumbjudge
_умная панель + глупый судья_  
panel=[deepseek-v4-pro, glm-5.1, kimi-k2.6] | judge=qwen3-8b | cost=$0.0422 | 228.4s | ptok=11511 ctok=1880 | retries=0

**consensus:**
  - The 2023 Nobel Prize in Physiology or Medicine was awarded jointly to Katalin Karikó and Drew Weissman for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.

**contradictions:**
  _(пусто)_

**unique_insights:**
  - {"model": "moonshotai/kimi-k2.6", "insight": "The Karolinska Institutet press release provided detailed mechanistic background on dendritic cell recognition of in vitro mRNA and base modifications."}
  - {"model": "moonshotai/kimi-k2.6", "insight": "Follow-up studies (2008, 2010) showed base-modified mRNA increased protein production by reducing enzyme activation."}

**blind_spots:**
  - Role of other researchers in mRNA technology development
  - Ethical considerations in vaccine development
  - Long-term implications of mRNA technology beyond the pandemic

**partial_coverage:**
  - {"models": ["moonshotai/kimi-k2.6"], "point": "Details about Karolinska Institutet press release, laureates' affiliations, and birth dates"}

### C5inv_dumbpanel_smartjudge
_глупая панель + умный судья (qwen-2.5-7b → gemma-3-12b-it)_  
panel=[qwen3-8b, gemma-3-12b-it, glm-4.7-flash] | judge=glm-5.1 | cost=$0.0655 | 162.3s | ptok=14667 ctok=2673 | retries=0

**consensus:**
  - The 2023 Nobel Prize in Physiology or Medicine was jointly awarded to Katalin Karikó and Drew Weissman.
  - The prize was for discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.
  - The key discovery was that modifying nucleoside bases in mRNA reduces inflammatory immune responses and enhances protein production/translation.
  - Their foundational work predated the COVID-19 pandemic and was critical for the rapid development of mRNA vaccines.

**contradictions:**
  _(пусто)_

**unique_insights:**
  - {"model": "google/gemma-3-12b-it", "insight": "Raises ethical considerations surrounding mRNA technology, including equitable global access and potential misuse — connecting the Nobel award to broader sociopolitical questions about who benefited from the technology."}
  - {"model": "qwen/qwen3-8b", "insight": "Notes the 15-year gap between the 2005 foundational publication and the COVID-19 pandemic, highlighting the long lag between basic discovery and clinical application."}

**blind_spots:**
  - The specific modified nucleoside was pseudouridine (Ψ) — no model names the actual chemical modification central to the discovery.
  - The mechanism involves Toll-like receptors (TLR3, TLR7, TLR8) recognizing unmodified RNA as foreign — no model details this immune signaling pathway.
  - The 2005 manuscript was rejected by Nature and Science before publication in Immunity — a significant episode in the discovery narrative omitted by all models.
  - Lipid nanoparticle (LNP) delivery systems were equally essential for mRNA vaccine efficacy but are not discussed by any model as a complementary enabling technology.
  - Controversy surrounding the Nobel award — including criticism that the prize implicitly endorsed vaccine safety without addressing lingering concerns, and questions about other contributors (e.g., Robert Malone's foundational mRNA work) being overlooked — is absent from all responses.
  - The PKR/eIF-2α pathway, by which pseudouridine-containing mRNA avoids translation inhibition, is the second key mechanism (beyond TLR suppression) and is not detailed by any model.

**partial_coverage:**
  - {"models": ["qwen/qwen3-8b"], "point": "Prize share was 1/2 each; announced on October 2, 2023 by Secretary-General Thomas Perlmann of the Nobel Assembly at Karolinska Institutet."}
  - {"models": ["z-ai/glm-4.7-flash"], "point": "Specifically identifies the chronological progression of key publications in 2005, 2008, and 2010 as building the foundation for mRNA vaccines."}
  - {"models": ["google/gemma-3-12b-it"], "point": "Details Karikó's career struggles including demotions and funding difficulties, and notes potential biases (gender, immigrant status) affecting her career trajectory."}

### C6_echo
_контроль: эхо-камера_  
panel=[qwen3-235b-a22b-2507, qwen3-235b-a22b-2507, qwen3-235b-a22b-2507] | judge=qwen3-235b-a22b-2507 | cost=$0.0303 | 99.0s | ptok=20747 ctok=4178 | retries=0

**consensus:**
  - Katalin Karikó and Drew Weissman received the 2023 Nobel Prize in Physiology or Medicine.
  - They were awarded for their discoveries concerning nucleoside base modifications in mRNA.
  - Their work enabled the development of effective mRNA vaccines against COVID-19.
  - Their modifications reduced inflammatory responses to in vitro transcribed mRNA.
  - The modifications also increased protein production in cells, overcoming key clinical barriers.
  - Their seminal findings were first published in 2005, with further work in 2008 and 2010.

**contradictions:**
  _(пусто)_

**unique_insights:**
  - {"model": "qwen/qwen3-235b-a22b-2507", "insight": "The 2005 discovery explained that the lack of base modifications in in vitro mRNA caused it to be recognized as foreign by dendritic cells, leading to inflammation, and that modified bases prevented this."}

**blind_spots:**
  - None of the models mention the role of pseudouridine specifically as the key modified base used in the breakthrough.
  - No model notes that Karikó faced decades of professional marginalization and funding rejection prior to recognition.
  - The broader implications for non-infectious disease treatments, such as cancer immunotherapies using mRNA, are not elaborated despite being highlighted in the official press release.
  - No model mentions the specific enzymes involved, such as the reduction in PKR activation contributing to increased protein translation.
  - The critical role of lipid nanoparticle delivery systems as a complementary technological development is omitted entirely.

**partial_coverage:**
  - {"models": ["qwen/qwen3-235b-a22b-2507"], "point": "The results were published in 2005, 2008, and 2010."}

### C3_cn_small
_всё мелкое_  
panel=[qwen3.6-27b, glm-4.7-flash, qwen3-32b] | judge=qwen3-32b | cost=$0.0234 | 237.1s | ptok=10363 ctok=1599 | retries=0

**consensus:**
  - The 2023 Nobel Prize in Physiology or Medicine was awarded jointly to Katalin Karikó and Drew Weissman.
  - They were honored for discoveries concerning nucleoside base modifications enabling the development of effective mRNA vaccines against COVID-19.
  - Their key discovery involved chemically modifying mRNA bases to reduce immune-inflammatory responses while enhancing protein production.
  - This breakthrough occurred in 2005, with follow-up studies in 2008 and 2010, and formed the foundation for mRNA vaccines during the pandemic.

**contradictions:**
  _(пусто)_

**unique_insights:**
  - {"model": "qwen/qwen3.6-27b", "insight": "Structural framing of the discovery (problem-discovery-result) with emphasis on inhibiting enzyme regulation of protein synthesis."}
  - {"model": "qwen/qwen3-32b", "insight": "Quantified protein expression metrics (10-100x increases) and focus on dendritic cell activation suppression as a key breakthrough."}

**blind_spots:**
  - No discussion of potential controversies or alternative approaches in mRNA vaccine development.
  - Lack of references to institutional or collaborative contributions beyond Karikó and Weissman.
  - No mention of the broader implications of nucleoside modification research beyond the pandemic.
  - Absence of analysis on the Nobel Committee's rationale for prioritizing this discovery over other competing breakthroughs.

**partial_coverage:**
  - {"models": ["qwen/qwen3.6-27b", "qwen/qwen3-32b"], "point": "Specific mention of modified nucleosides avoiding immune recognition and enabling higher translational efficiency (10-100x protein production increases)."}
  - {"models": ["qwen/qwen3-32b"], "point": "Explicit reference to pseudouridine as the modified base used in RNA."}


---
## BASELINE (одиночная модель, без fusion)

### B_cn  (model=deepseek-v4-pro | cost=$0.0003 | 3.6s)
The 2023 Nobel Prize in Physiology or Medicine was awarded jointly to **Katalin Karikó** and **Drew Weissman** for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.

### B_west  (model=gpt-5.2 | cost=$0.0013 | 3.0s)
The **2023 Nobel Prize in Physiology or Medicine** was awarded to **Katalin Karikó** and **Drew Weissman** for their discovery that **modifications to nucleosides in messenger RNA (mRNA)** can **reduce inflammatory immune responses and increase the stability/translation of mRNA**—a breakthrough that enabled the development of **effective mRNA vaccines**, including those used against **COVID‑19**.
